Leaving Practice During the Era of Covid-19
June 5, 2020
TO OUR POLICY HOLDERS:
The impacts of the COVID-19 virus will cause some physicians to make changes to their practice situation by seeking a position at a new practice, transitioning to a job that does not involve patient care, or choosing to retire. Regardless of the type of change, physicians must meet certain obligations when leaving or selling a practice. OMIC’s Leaving practice toolkit outlines the steps physicians and practices need to take to promote continuity of care, prevent allegations of abandonment, and preserve the medical records. Preparing for the change will help decrease the associated stress and the likelihood of lawsuits.
Contact OMIC’s Risk Management department if you have questions by calling 1-800-562-6642 and enter “4” for Risk Management, or email us at riskmanagement@omic.com
We are committed to supporting you, our insureds, through this challenging time. Please remain safe
New and Revised Resources
August 6, 2020
We are pleased to provide some new and revised resources; please use the links to access them.
Ophthalmic anesthesia claims
OMIC policyholder Dr. Michael Morley, anesthesiologist Dr. Karin Nanji, and OMIC Patient Safety Manager Anne Menke analyzed 10 years of ophthalmic anesthesia claims. “Ocular Anesthesia-Related Closed Claims from Ophthalmic Mutual Insurance Company 2008-2018” is available in the July 2020 issue of Ophthalmology.
https://www.aaojournal.org/article/S0161-6420(19)32371-1/fulltext
New: DURYSTA recommendations and consent
The FDA approved the DURYSTA implant in June 2020 for the treatment of open-angle glaucoma. OMIC prepared risk management recommendations to address the risk of endothelial cell loss and a sample consent form to help educate patients about the risks and benefits.
DURYSTA recommendations/consent form
Revised: recommendations and consent forms for intravitreal triamcinolone acetonide
Ophthalmologists regularly administer this medication. We have updated our recommendations and prepared consent forms for Kenalog and Triesence.
Call the OMIC Hotline for confidential advice on any risk management issue. We’re here to help!
Phone: 800.562.6642 (Press 4)
Email: riskmanagement@omic.com
Plan Ahead For Your OMIC Risk Management Discount
August 14, 2020
OMIC renews insureds’ policies and issues premium invoices well ahead of their effective dates in order to provide the best customer service to our policyholders and to meet their credentialing requirements.
In order for OMIC to provide the most accurate invoice at the time of renewal, we encourage policyholders to complete their risk management courses 75 days or more prior to the actual renewal effective date of the policy. This ensures that your invoice will be accurate at the time of renewal.
OMIC’s Risk Management courses not only provide ophthalmic-specific patient safety and practice management strategies, but also provide premium discounts of 5% or 10% for completing those courses.
You can view our live and online courses by following these links: OMIC Live Seminars and OMIC Online and Recorded Courses.
To take advantage of this benefit, please contact our Risk Management Coordinator, Linda Nakamura, at lnakamura@omic.com or call 415-202-4652.
